Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


LFB Biotechnologies SAS

Division of LFB SA

Latest From Oncogenerix Inc.

DARA Divests Diabetes Compound; Shifts Focus To Oncology

The North Carolina company has washed its hands of development-stage assets and now is ready to be a strictly commercial-stage company focused on oncology support products.

BioPharmaceutical Strategy

Deals Shaping the Medical Industry (2/2012)

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

Medical Device BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
    • Transgenics
  • Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Immune Disorders
  • Alias(es)
  • LFB Biotechnologies
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • LFB SA
  • Senior Management
  • Contact Info
  • LFB Biotechnologies SAS
    Phone: (33) 69 82 70 10
    3, avenue des Tropiques B.P. 305
    Les Ulis
    Courtabeuf Cedex , 91958